Search

Your search keyword '"Katja K.H. Aben"' showing total 228 results

Search Constraints

Start Over You searched for: Author "Katja K.H. Aben" Remove constraint Author: "Katja K.H. Aben"
228 results on '"Katja K.H. Aben"'

Search Results

1. The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer

2. Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

3. Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort

4. Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?

5. Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands

6. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

7. Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study

9. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

10. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

11. Supplementary Tables 1-7 from Genome-Wide Significant Association Between a Sequence Variant at 15q15.2 and Lung Cancer Risk

12. Data from Genome-Wide Significant Association Between a Sequence Variant at 15q15.2 and Lung Cancer Risk

13. Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer

14. Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk

15. Histopathological re-evaluations of biopsies in prostate cancer: a nationwide observational study

16. Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer

17. Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands

18. Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands

19. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer

20. Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer

21. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study

22. Predictors of surgical treatment burden, outcomes, and overall survival in older adults with basal cell carcinoma: Results from the prospective, multicenter BATOA cohort

23. Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections

24. High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients:Results from the Dutch CAPRI-Registry

25. Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma

26. The global burden of urinary bladder cancer: an update

27. Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit

28. Bladder cancer survival: Women only fare worse in the first two years after diagnosis

29. Nationwide treatment patterns and survival of older patients with prostate cancer

30. Kwaliteitsregistratie prostaatcarcinoom: ziekenhuisregistratie versus Nederlandse Kankerregistratie

31. Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI

32. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017

33. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

34. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 questionnaire module for patients with non-muscle-invasive bladder cancer

35. Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry

36. Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study

37. Low Risk of Severe Complications After A Single, Post-Operative Instillation of Intravesical Chemotherapy in Patients with TaG1G2 Urothelial Bladder Carcinoma

38. Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer

39. OC-0512 Impact of modern radiotherapy on subsequent hematological cancer risk in prostate cancer survivors

40. Intermediate-term overall survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non muscle-invasive bladder cancer in the Netherlands

42. Radical prostatectomy versus deferred treatment for localised prostate cancer

43. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

44. Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study

45. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression

46. Immediate treatment vs. active-surveillance in very-low-risk prostate cancer: the role of patient-, tumour-, and hospital-related factors

47. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer

49. Very low risk of severe complications after a single, post-operative instillation of intravesical chemotherapy in patients with low- or intermediate risk urothelial carcinoma of the bladder

Catalog

Books, media, physical & digital resources